ICL-CCIC-0019

SKU: orb1305063

Description

ICL-CCIC-0019 is a small molecule inhibitor targeting choline kinase alpha (ChoKα). It triggers G1 cell cycle arrest, endoplasmic reticulum stress, and apoptotic cell death in cancer cell lines, making it a useful tool for investigating oncology pathways in vitro.

Research Area

Cell Biology, Neuroscience

Key Properties

• CAS Number: 936498-64-5
• MW: 572.46
• Purity: 99.54% (May vary between batches)
• Formula: C₂₆H₄₄Br₂N₄
• SMILES: CN(C1=CC=[N+](CCCCCCCCCCCC[N+]2=CC=C(N(C)C)C=C2)C=C1)C.[Br-].[Br-]
• Target: AChR,Apoptosis
• Solubility: DMSO:20 mg/mL (34.94 mM);10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (3.49 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ICL CCIC 0019, ICL CCIC0019, ICL CCIC-0019, ICL-CCIC 0019, ICLCCIC0019, ICL-CCIC0019, ICL-CCIC-0019, choline kinase alpha (ChoKα)

Compound Identifiers

PubChem CID

44423477